Glenmark Pharma has come out with very poor third quarter numbers of FY09. Its Q3 consolidated net profit went down 52% at Rs 135 crore from Rs 280 crore. Its look very week on the charts. Glenmark pharma has strong support around 130 levels. If it break below 130 then it going to touch 115. I prefer to sell but if you want to average it then do it around new lows.